Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients
- 8 July 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 118 (2), e48-53
- https://doi.org/10.1161/CIRCULATIONAHA.107.189627
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The Metabolic Syndrome and the Impact of Diabetes on Coronary Heart Disease Mortality in Women and Men: The San Antonio Heart StudyAnnals of Epidemiology, 2007
- Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseJournal of Clinical Endocrinology & Metabolism, 2007
- Cardiovascular Risks of Antiretroviral TherapyNew England Journal of Medicine, 2007
- Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient PopulationClinical Infectious Diseases, 2007
- Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA studyJournal of Epidemiology and Community Health, 2007
- Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic SyndromeJournal of Clinical Endocrinology & Metabolism, 2006
- Subclinical Carotid Atherosclerosis in HIV-Infected PatientsStroke, 2006
- Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjectsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004